Texas House of Representatives · 90th Legislature, Regular Session
Official title: Relating to the medical use of low-THC cannabis by patients with a medical condition that causes menstrual cramps.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)90R
The bill changes Section 169.003(a) of the Occupations Code, which sets out when a physician may prescribe low-THC cannabis (a cannabis product with a limited amount of THC, the substance that causes a high). It adds a new qualifying diagnosis to the existing list: a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea. Under the bill, a physician described by Section 169.002 may prescribe low-THC cannabis to a patient with such a condition if the patient is a permanent resident of Texas and the physician complies with the registration requirements of Section 169.004. The physician must also certify to the department that the patient has the diagnosis. The physician must further determine that the risk of the patient's medical use of low-THC cannabis is reasonable in light of the potential benefit to the patient. The bill leaves the other listed conditions in place, including epilepsy, cancer, post-traumatic stress disorder, and conditions approved for a research program under Subchapter F, Chapter 487, Health and Safety Code. The bill does not create a new program, fee, or agency, and its cost is not stated in the bill text. It takes effect September 1, 2027.
Read the full text below for the definitive meaning.
Each version links to the authoritative document on capitol.texas.gov.
90R1732 LHC-D By: Plesa H.B. No. 330 A BILL TO BE ENTITLED AN ACT relating to the medical use of low-THC cannabis by patients with a medical condition that causes menstrual cramps. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 169.003(a), Occupations Code, is amended to read as follows: (a) A physician described by Section 169.002 may prescribe
low-THC cannabis to a patient if: (1) the patient is a permanent resident of the state; (2) the physician complies with the registration requirements of Section 169.004; and (3) the physician certifies to the department that: (A) the patient is diagnosed with: (i) epilepsy; (ii) a seizure disorder; (iii) multiple sclerosis; (iv) spasticity; (v) amyotrophic lateral sclerosis; (vi) autism; (vii) cancer; (viii) an incurable neurodegenerative disease; (ix) post-traumatic stress disorder; (x) a condition that causes chronic pain; (xi) traumatic brain injury; (xii) Crohn's disease or other inflammatory bowel disease; (xiii) a terminal illness or a condition for which a patient is receiving hospice or palliative care; [ or ] (xiv) a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea; or (xv) a medical condition that is approved for a research program under Subchapter F, Chapter 487, Health and Safety Code, and for which the patient is receiving treatment under that program; and (B) the physician determines the risk of the medical use of low-THC cannabis by the patient is reasonable in light of the potential benefit for the patient. SECTION 2. This Act takes effect September 1, 2027.
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 90R bills tagged the same way.
Source
SourceTexas Legislative Council (capitol.texas.gov)90R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)90R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)